TY - JOUR
T1 - A population-based epidemiological survey of human parvovirus B19 infection
T2 - A project of the Kyushu and Okinawa Population Study (KOPS)
AU - Ihara, Takeshi
AU - Furusyo, Norihiro
AU - Hayashi, Takeo
AU - Toyoda, Kazuhiro
AU - Murata, Masayuki
AU - Hayashi, Jun
N1 - Funding Information:
This work was supported in part by the Japan Multi-Institutional Collaborative Cohort Study (J-MICC Study), Scientific Support Program for Cancer Research Grant-in-Aid for Scientific Research on Innovative Areas (no. 221 S001), and Grant-in-Aid for Comprehensive Research of the 21st Century COE Program from the Ministry of Education, Culture, Sports Science and Technology in Japan.
PY - 2013/12
Y1 - 2013/12
N2 - Human parvovirus B19 infection occurs by droplet nuclei through the respiratory tract and causes a wide range of diseases. It can be transmitted through blood transfusion from asymptomatic blood donors. This study was done to investigate the parvovirus B19 infection rate of a group of healthy Japanese residents. Of 2,081 blood samples tested, 15 (0.72 %) were positive for parvovirus B19 IgM, 1,412 (67.9 %) for B19 virus IgG, and 4 (0.2 %) for parvovirus B19 DNA. About half of all women of childbearing age were susceptible to parvovirus B19 infection. No relationship was found between the frequency of symptoms and the prevalence of parvovirus B19 IgG and IgM, suggesting that there are asymptomatic carriers in the healthy Japanese population. There is a risk of parvovirus B19 infection by blood transfusion from asymptomatic donors and that pregnant women are at high risk for parvovirus B19 infection.
AB - Human parvovirus B19 infection occurs by droplet nuclei through the respiratory tract and causes a wide range of diseases. It can be transmitted through blood transfusion from asymptomatic blood donors. This study was done to investigate the parvovirus B19 infection rate of a group of healthy Japanese residents. Of 2,081 blood samples tested, 15 (0.72 %) were positive for parvovirus B19 IgM, 1,412 (67.9 %) for B19 virus IgG, and 4 (0.2 %) for parvovirus B19 DNA. About half of all women of childbearing age were susceptible to parvovirus B19 infection. No relationship was found between the frequency of symptoms and the prevalence of parvovirus B19 IgG and IgM, suggesting that there are asymptomatic carriers in the healthy Japanese population. There is a risk of parvovirus B19 infection by blood transfusion from asymptomatic donors and that pregnant women are at high risk for parvovirus B19 infection.
UR - http://www.scopus.com/inward/record.url?scp=84888014589&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84888014589&partnerID=8YFLogxK
U2 - 10.1007/s00705-013-1746-z
DO - 10.1007/s00705-013-1746-z
M3 - Article
C2 - 23775357
AN - SCOPUS:84888014589
SN - 0304-8608
VL - 158
SP - 2465
EP - 2472
JO - Archives of Virology
JF - Archives of Virology
IS - 12
ER -